Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Total Non-Current Liabilities: 2020-2022

Historic Total Non-Current Liabilities for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $9.0 million.

  • Terns Pharmaceuticals' Total Non-Current Liabilities rose 48.48% to $12.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.2 million, marking a year-over-year increase of 48.48%. This contributed to the annual value of $9.0 million for FY2022, which is 29.11% up from last year.
  • Latest data reveals that Terns Pharmaceuticals reported Total Non-Current Liabilities of $9.0 million as of FY2022, which was up 29.11% from $7.0 million recorded in FY2021.
  • In the past 5 years, Terns Pharmaceuticals' Total Non-Current Liabilities ranged from a high of $23.0 million in FY2020 and a low of $7.0 million during FY2021.
  • Over the past 3 years, Terns Pharmaceuticals' median Total Non-Current Liabilities value was $9.0 million (recorded in 2022), while the average stood at $13.0 million.
  • As far as peak fluctuations go, Terns Pharmaceuticals' Total Non-Current Liabilities crashed by 69.71% in 2021, and later grew by 29.11% in 2022.
  • Terns Pharmaceuticals' Total Non-Current Liabilities (Yearly) stood at $23.0 million in 2020, then tumbled by 69.71% to $7.0 million in 2021, then grew by 29.11% to $9.0 million in 2022.